# TIGECYCLINE
> **ANDA205722** · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2019-10-18
## Drug
- **FDA Application Number:** ANDA205722
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TIGECYCLINE
- **Generic name:** Tigecycline
- **Active ingredients:** TIGECYCLINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** XELLIA PHARMS APS
- **First approval:** 2019-10-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205722)
---
*AI Analytics · CC0 1.0*